Tracking SARS-CoV-2 seropositivity in rural communities using blood-fed mosquitoes: a proof-of-concept study Article Swipe
Benjamin J. Krajacich
,
Djibril Samaké
,
Adama Dao
,
Moussa Diallo
,
Zana L. Sanogo
,
Alpha Seydou Yaro
,
Amatigué Zéguimé
,
Josué Poudiougo
,
Kadiatou Cissé
,
Mamadou Traoré
,
Alassane dit Assitoun
,
Roy Faiman
,
Irfan Zaidi
,
John Woodford
,
Patrick E. Duffy
,
Tovi Lehmann
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.3389/fepid.2023.1243691
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.3389/fepid.2023.1243691
Background The spread of SARS-CoV-2 cannot be well monitored and understood in areas without capacity for effective disease surveillance. Countries with a young population will have disproportionately large numbers of asymptomatic or pauci-symptomatic infections, further hindering detection of infection. Sero-surveillance on a country-wide scale by trained medical professionals may be limited in a resource-limited setting such as Mali. Novel ways of broadly sampling the human population in a non-invasive method would allow for large-scale surveillance at a reduced cost. Approach Here we evaluate the collection of naturally blood-fed mosquitoes to test for human anti-SARS-CoV-2 antibodies in the laboratory and at five field locations in Mali. Results Immunoglobulin-G antibodies to multiple SARS-CoV-2 antigens were readily detected in mosquito bloodmeals by bead-based immunoassay through at least 10 h after feeding [mean sensitivity of 0.92 (95% CI 0.78–1) and mean specificity of 0.98 (95% CI 0.88–1)], indicating that most blood-fed mosquitoes collected indoors during early morning hours (and likely to have fed the previous night) are viable samples for analysis. We found that reactivity to four SARS-CoV-2 antigens rose during the pandemic from pre-pandemic levels. The crude seropositivity of blood sampled via mosquitoes was 6.3% in October and November 2020 across all sites, and increased to 25.1% overall by February 2021, with the most urban site reaching 46.7%, consistent with independent venous blood-based sero-surveillance estimates. Conclusions We have demonstrated that using mosquito bloodmeals, country-wide sero-surveillance of human diseases (both vector-borne and non-vector-borne) is possible in areas where human-biting mosquitoes are common, offering an informative, cost-effective, and non-invasive sampling option.
Related Topics
Concepts
Population
Dengue fever
Asymptomatic
Medicine
Antibody
Pandemic
Virology
Immunoassay
Serology
Immunology
Veterinary medicine
Environmental health
Coronavirus disease 2019 (COVID-19)
Infectious disease (medical specialty)
Disease
Internal medicine
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3389/fepid.2023.1243691
- https://www.frontiersin.org/articles/10.3389/fepid.2023.1243691/pdf?isPublishedV2=False
- OA Status
- diamond
- References
- 40
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4389686820
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4389686820Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fepid.2023.1243691Digital Object Identifier
- Title
-
Tracking SARS-CoV-2 seropositivity in rural communities using blood-fed mosquitoes: a proof-of-concept studyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-12-13Full publication date if available
- Authors
-
Benjamin J. Krajacich, Djibril Samaké, Adama Dao, Moussa Diallo, Zana L. Sanogo, Alpha Seydou Yaro, Amatigué Zéguimé, Josué Poudiougo, Kadiatou Cissé, Mamadou Traoré, Alassane dit Assitoun, Roy Faiman, Irfan Zaidi, John Woodford, Patrick E. Duffy, Tovi LehmannList of authors in order
- Landing page
-
https://doi.org/10.3389/fepid.2023.1243691Publisher landing page
- PDF URL
-
https://www.frontiersin.org/articles/10.3389/fepid.2023.1243691/pdf?isPublishedV2=FalseDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://www.frontiersin.org/articles/10.3389/fepid.2023.1243691/pdf?isPublishedV2=FalseDirect OA link when available
- Concepts
-
Population, Dengue fever, Asymptomatic, Medicine, Antibody, Pandemic, Virology, Immunoassay, Serology, Immunology, Veterinary medicine, Environmental health, Coronavirus disease 2019 (COVID-19), Infectious disease (medical specialty), Disease, Internal medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
40Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4389686820 |
|---|---|
| doi | https://doi.org/10.3389/fepid.2023.1243691 |
| ids.doi | https://doi.org/10.3389/fepid.2023.1243691 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38455906 |
| ids.openalex | https://openalex.org/W4389686820 |
| fwci | 0.0 |
| type | article |
| title | Tracking SARS-CoV-2 seropositivity in rural communities using blood-fed mosquitoes: a proof-of-concept study |
| biblio.issue | |
| biblio.volume | 3 |
| biblio.last_page | 1243691 |
| biblio.first_page | 1243691 |
| topics[0].id | https://openalex.org/T10166 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2739 |
| topics[0].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[0].display_name | Mosquito-borne diseases and control |
| topics[1].id | https://openalex.org/T10118 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9926999807357788 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[2].id | https://openalex.org/T12047 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9912999868392944 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2725 |
| topics[2].subfield.display_name | Infectious Diseases |
| topics[2].display_name | Viral Infections and Vectors |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2908647359 |
| concepts[0].level | 2 |
| concepts[0].score | 0.601985514163971 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[0].display_name | Population |
| concepts[1].id | https://openalex.org/C533803919 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5898467302322388 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q30953 |
| concepts[1].display_name | Dengue fever |
| concepts[2].id | https://openalex.org/C2777910003 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5703527927398682 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1707292 |
| concepts[2].display_name | Asymptomatic |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.5431702136993408 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C159654299 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5240412354469299 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[4].display_name | Antibody |
| concepts[5].id | https://openalex.org/C89623803 |
| concepts[5].level | 5 |
| concepts[5].score | 0.5182766318321228 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12184 |
| concepts[5].display_name | Pandemic |
| concepts[6].id | https://openalex.org/C159047783 |
| concepts[6].level | 1 |
| concepts[6].score | 0.44194960594177246 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[6].display_name | Virology |
| concepts[7].id | https://openalex.org/C2780420688 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4407021999359131 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q759183 |
| concepts[7].display_name | Immunoassay |
| concepts[8].id | https://openalex.org/C45189115 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4379218518733978 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q502159 |
| concepts[8].display_name | Serology |
| concepts[9].id | https://openalex.org/C203014093 |
| concepts[9].level | 1 |
| concepts[9].score | 0.4369274973869324 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[9].display_name | Immunology |
| concepts[10].id | https://openalex.org/C42972112 |
| concepts[10].level | 1 |
| concepts[10].score | 0.333684504032135 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q170201 |
| concepts[10].display_name | Veterinary medicine |
| concepts[11].id | https://openalex.org/C99454951 |
| concepts[11].level | 1 |
| concepts[11].score | 0.31673550605773926 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[11].display_name | Environmental health |
| concepts[12].id | https://openalex.org/C3008058167 |
| concepts[12].level | 4 |
| concepts[12].score | 0.2858150005340576 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[12].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[13].id | https://openalex.org/C524204448 |
| concepts[13].level | 3 |
| concepts[13].score | 0.23747488856315613 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[13].display_name | Infectious disease (medical specialty) |
| concepts[14].id | https://openalex.org/C2779134260 |
| concepts[14].level | 2 |
| concepts[14].score | 0.23221033811569214 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[14].display_name | Disease |
| concepts[15].id | https://openalex.org/C126322002 |
| concepts[15].level | 1 |
| concepts[15].score | 0.2016335427761078 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[15].display_name | Internal medicine |
| keywords[0].id | https://openalex.org/keywords/population |
| keywords[0].score | 0.601985514163971 |
| keywords[0].display_name | Population |
| keywords[1].id | https://openalex.org/keywords/dengue-fever |
| keywords[1].score | 0.5898467302322388 |
| keywords[1].display_name | Dengue fever |
| keywords[2].id | https://openalex.org/keywords/asymptomatic |
| keywords[2].score | 0.5703527927398682 |
| keywords[2].display_name | Asymptomatic |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.5431702136993408 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/antibody |
| keywords[4].score | 0.5240412354469299 |
| keywords[4].display_name | Antibody |
| keywords[5].id | https://openalex.org/keywords/pandemic |
| keywords[5].score | 0.5182766318321228 |
| keywords[5].display_name | Pandemic |
| keywords[6].id | https://openalex.org/keywords/virology |
| keywords[6].score | 0.44194960594177246 |
| keywords[6].display_name | Virology |
| keywords[7].id | https://openalex.org/keywords/immunoassay |
| keywords[7].score | 0.4407021999359131 |
| keywords[7].display_name | Immunoassay |
| keywords[8].id | https://openalex.org/keywords/serology |
| keywords[8].score | 0.4379218518733978 |
| keywords[8].display_name | Serology |
| keywords[9].id | https://openalex.org/keywords/immunology |
| keywords[9].score | 0.4369274973869324 |
| keywords[9].display_name | Immunology |
| keywords[10].id | https://openalex.org/keywords/veterinary-medicine |
| keywords[10].score | 0.333684504032135 |
| keywords[10].display_name | Veterinary medicine |
| keywords[11].id | https://openalex.org/keywords/environmental-health |
| keywords[11].score | 0.31673550605773926 |
| keywords[11].display_name | Environmental health |
| keywords[12].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[12].score | 0.2858150005340576 |
| keywords[12].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[13].id | https://openalex.org/keywords/infectious-disease |
| keywords[13].score | 0.23747488856315613 |
| keywords[13].display_name | Infectious disease (medical specialty) |
| keywords[14].id | https://openalex.org/keywords/disease |
| keywords[14].score | 0.23221033811569214 |
| keywords[14].display_name | Disease |
| keywords[15].id | https://openalex.org/keywords/internal-medicine |
| keywords[15].score | 0.2016335427761078 |
| keywords[15].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.3389/fepid.2023.1243691 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210179157 |
| locations[0].source.issn | 2674-1199 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2674-1199 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Epidemiology |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.frontiersin.org/articles/10.3389/fepid.2023.1243691/pdf?isPublishedV2=False |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Epidemiology |
| locations[0].landing_page_url | https://doi.org/10.3389/fepid.2023.1243691 |
| locations[1].id | pmid:38455906 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Frontiers in epidemiology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38455906 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10911011 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10911011/pdf/fepid-03-1243691.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Front Epidemiol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10911011 |
| locations[3].id | pmh:oai:doaj.org/article:db6af8233cf34b83a868310084e65c5c |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Frontiers in Epidemiology, Vol 3 (2023) |
| locations[3].landing_page_url | https://doaj.org/article/db6af8233cf34b83a868310084e65c5c |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5003873704 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5769-8946 |
| authorships[0].author.display_name | Benjamin J. Krajacich |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210159747 |
| authorships[0].affiliations[0].raw_affiliation_string | Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD, United States |
| authorships[0].institutions[0].id | https://openalex.org/I4210159747 |
| authorships[0].institutions[0].ror | https://ror.org/05mkxvs25 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210159747 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Vector Oncology (United States) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Benjamin J. Krajacich |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD, United States |
| authorships[1].author.id | https://openalex.org/A5035828689 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-6053-1028 |
| authorships[1].author.display_name | Djibril Samaké |
| authorships[1].affiliations[0].raw_affiliation_string | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Djibril Samaké |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[2].author.id | https://openalex.org/A5089773450 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Adama Dao |
| authorships[2].affiliations[0].raw_affiliation_string | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Adama Dao |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[3].author.id | https://openalex.org/A5030523651 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Moussa Diallo |
| authorships[3].affiliations[0].raw_affiliation_string | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Moussa Diallo |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[4].author.id | https://openalex.org/A5109589796 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Zana L. Sanogo |
| authorships[4].affiliations[0].raw_affiliation_string | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Zana Lamissa Sanogo |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[5].author.id | https://openalex.org/A5102139639 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Alpha Seydou Yaro |
| authorships[5].affiliations[0].raw_affiliation_string | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Alpha Seydou Yaro |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[6].author.id | https://openalex.org/A5006684163 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-3158-1907 |
| authorships[6].author.display_name | Amatigué Zéguimé |
| authorships[6].affiliations[0].raw_affiliation_string | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Amatigue Zeguime |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[7].author.id | https://openalex.org/A5088228177 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Josué Poudiougo |
| authorships[7].affiliations[0].raw_affiliation_string | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Josué Poudiougo |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[8].author.id | https://openalex.org/A5042231430 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Kadiatou Cissé |
| authorships[8].affiliations[0].raw_affiliation_string | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Kadiatou Cissé |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[9].author.id | https://openalex.org/A5057282287 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-0558-1724 |
| authorships[9].author.display_name | Mamadou Traoré |
| authorships[9].affiliations[0].raw_affiliation_string | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Mamadou Traoré |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[10].author.id | https://openalex.org/A5017332847 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Alassane dit Assitoun |
| authorships[10].affiliations[0].raw_affiliation_string | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Alassane dit Assitoun |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Malaria Research and Training Center (MRTC)/Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Sciences, Techniques and Technologies, Bamako, Mali |
| authorships[11].author.id | https://openalex.org/A5033259042 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-9997-7801 |
| authorships[11].author.display_name | Roy Faiman |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210159747 |
| authorships[11].affiliations[0].raw_affiliation_string | Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD, United States |
| authorships[11].institutions[0].id | https://openalex.org/I4210159747 |
| authorships[11].institutions[0].ror | https://ror.org/05mkxvs25 |
| authorships[11].institutions[0].type | company |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210159747 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Vector Oncology (United States) |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Roy Faiman |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD, United States |
| authorships[12].author.id | https://openalex.org/A5050112210 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-9161-2050 |
| authorships[12].author.display_name | Irfan Zaidi |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I1299303238, https://openalex.org/I4210134534 |
| authorships[12].affiliations[0].raw_affiliation_string | Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States |
| authorships[12].institutions[0].id | https://openalex.org/I4210134534 |
| authorships[12].institutions[0].ror | https://ror.org/043z4tv69 |
| authorships[12].institutions[0].type | facility |
| authorships[12].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210134534 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | National Institute of Allergy and Infectious Diseases |
| authorships[12].institutions[1].id | https://openalex.org/I1299303238 |
| authorships[12].institutions[1].ror | https://ror.org/01cwqze88 |
| authorships[12].institutions[1].type | government |
| authorships[12].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238 |
| authorships[12].institutions[1].country_code | US |
| authorships[12].institutions[1].display_name | National Institutes of Health |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Irfan Zaidi |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States |
| authorships[13].author.id | https://openalex.org/A5016702194 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-8363-5495 |
| authorships[13].author.display_name | John Woodford |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I1299303238, https://openalex.org/I4210134534 |
| authorships[13].affiliations[0].raw_affiliation_string | Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States |
| authorships[13].institutions[0].id | https://openalex.org/I4210134534 |
| authorships[13].institutions[0].ror | https://ror.org/043z4tv69 |
| authorships[13].institutions[0].type | facility |
| authorships[13].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210134534 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | National Institute of Allergy and Infectious Diseases |
| authorships[13].institutions[1].id | https://openalex.org/I1299303238 |
| authorships[13].institutions[1].ror | https://ror.org/01cwqze88 |
| authorships[13].institutions[1].type | government |
| authorships[13].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238 |
| authorships[13].institutions[1].country_code | US |
| authorships[13].institutions[1].display_name | National Institutes of Health |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | John Woodford |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States |
| authorships[14].author.id | https://openalex.org/A5049967604 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-4483-5005 |
| authorships[14].author.display_name | Patrick E. Duffy |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I1299303238, https://openalex.org/I4210134534 |
| authorships[14].affiliations[0].raw_affiliation_string | Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States |
| authorships[14].institutions[0].id | https://openalex.org/I4210134534 |
| authorships[14].institutions[0].ror | https://ror.org/043z4tv69 |
| authorships[14].institutions[0].type | facility |
| authorships[14].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210134534 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | National Institute of Allergy and Infectious Diseases |
| authorships[14].institutions[1].id | https://openalex.org/I1299303238 |
| authorships[14].institutions[1].ror | https://ror.org/01cwqze88 |
| authorships[14].institutions[1].type | government |
| authorships[14].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238 |
| authorships[14].institutions[1].country_code | US |
| authorships[14].institutions[1].display_name | National Institutes of Health |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Patrick E. Duffy |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States |
| authorships[15].author.id | https://openalex.org/A5055609794 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-8142-3915 |
| authorships[15].author.display_name | Tovi Lehmann |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210159747 |
| authorships[15].affiliations[0].raw_affiliation_string | Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD, United States |
| authorships[15].institutions[0].id | https://openalex.org/I4210159747 |
| authorships[15].institutions[0].ror | https://ror.org/05mkxvs25 |
| authorships[15].institutions[0].type | company |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210159747 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Vector Oncology (United States) |
| authorships[15].author_position | last |
| authorships[15].raw_author_name | Tovi Lehmann |
| authorships[15].is_corresponding | True |
| authorships[15].raw_affiliation_strings | Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD, United States |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.frontiersin.org/articles/10.3389/fepid.2023.1243691/pdf?isPublishedV2=False |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Tracking SARS-CoV-2 seropositivity in rural communities using blood-fed mosquitoes: a proof-of-concept study |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-25T14:43:58.451035 |
| primary_topic.id | https://openalex.org/T10166 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2739 |
| primary_topic.subfield.display_name | Public Health, Environmental and Occupational Health |
| primary_topic.display_name | Mosquito-borne diseases and control |
| related_works | https://openalex.org/W4381663654, https://openalex.org/W2068304598, https://openalex.org/W2807168341, https://openalex.org/W2725116932, https://openalex.org/W2509622515, https://openalex.org/W1965818759, https://openalex.org/W2560223662, https://openalex.org/W2155365093, https://openalex.org/W4394881148, https://openalex.org/W1629764683 |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3389/fepid.2023.1243691 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210179157 |
| best_oa_location.source.issn | 2674-1199 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2674-1199 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Epidemiology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.frontiersin.org/articles/10.3389/fepid.2023.1243691/pdf?isPublishedV2=False |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Epidemiology |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fepid.2023.1243691 |
| primary_location.id | doi:10.3389/fepid.2023.1243691 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210179157 |
| primary_location.source.issn | 2674-1199 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2674-1199 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Epidemiology |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.frontiersin.org/articles/10.3389/fepid.2023.1243691/pdf?isPublishedV2=False |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Epidemiology |
| primary_location.landing_page_url | https://doi.org/10.3389/fepid.2023.1243691 |
| publication_date | 2023-12-13 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W3091913409, https://openalex.org/W3025631553, https://openalex.org/W3120636457, https://openalex.org/W3016269138, https://openalex.org/W3133612858, https://openalex.org/W3133467376, https://openalex.org/W3204478051, https://openalex.org/W2472518915, https://openalex.org/W4200398204, https://openalex.org/W3173785513, https://openalex.org/W2885676436, https://openalex.org/W1999294803, https://openalex.org/W2093884265, https://openalex.org/W1983343147, https://openalex.org/W6714149826, https://openalex.org/W1973435341, https://openalex.org/W2167170235, https://openalex.org/W2474114001, https://openalex.org/W3048518506, https://openalex.org/W3011906965, https://openalex.org/W786618, https://openalex.org/W2167239677, https://openalex.org/W3049246521, https://openalex.org/W3044446967, https://openalex.org/W2171594370, https://openalex.org/W2794609412, https://openalex.org/W2030006320, https://openalex.org/W1969128418, https://openalex.org/W2409080506, https://openalex.org/W1989552423, https://openalex.org/W2795709461, https://openalex.org/W2950701052, https://openalex.org/W2123923006, https://openalex.org/W6721026456, https://openalex.org/W6600037970, https://openalex.org/W3133439220, https://openalex.org/W2108124558, https://openalex.org/W2955763588, https://openalex.org/W3017092394, https://openalex.org/W3118395434 |
| referenced_works_count | 40 |
| abstract_inverted_index.a | 21, 41, 52, 67, 76 |
| abstract_inverted_index.h | 125 |
| abstract_inverted_index.10 | 124 |
| abstract_inverted_index.CI | 133, 141 |
| abstract_inverted_index.We | 167, 223 |
| abstract_inverted_index.an | 249 |
| abstract_inverted_index.as | 56 |
| abstract_inverted_index.at | 75, 99, 122 |
| abstract_inverted_index.be | 6, 49 |
| abstract_inverted_index.by | 44, 118, 205 |
| abstract_inverted_index.in | 11, 51, 66, 95, 103, 115, 192, 241 |
| abstract_inverted_index.is | 239 |
| abstract_inverted_index.of | 3, 29, 37, 60, 85, 130, 138, 185, 232 |
| abstract_inverted_index.on | 40 |
| abstract_inverted_index.or | 31 |
| abstract_inverted_index.to | 89, 108, 156, 171, 202 |
| abstract_inverted_index.we | 81 |
| abstract_inverted_index.The | 1, 182 |
| abstract_inverted_index.all | 198 |
| abstract_inverted_index.and | 9, 98, 135, 194, 200, 237, 252 |
| abstract_inverted_index.are | 162, 246 |
| abstract_inverted_index.fed | 158 |
| abstract_inverted_index.for | 15, 72, 91, 165 |
| abstract_inverted_index.may | 48 |
| abstract_inverted_index.the | 63, 83, 96, 159, 177, 209 |
| abstract_inverted_index.via | 188 |
| abstract_inverted_index.was | 190 |
| abstract_inverted_index.(95% | 132, 140 |
| abstract_inverted_index.(and | 154 |
| abstract_inverted_index.0.92 | 131 |
| abstract_inverted_index.0.98 | 139 |
| abstract_inverted_index.2020 | 196 |
| abstract_inverted_index.6.3% | 191 |
| abstract_inverted_index.Here | 80 |
| abstract_inverted_index.five | 100 |
| abstract_inverted_index.four | 172 |
| abstract_inverted_index.from | 179 |
| abstract_inverted_index.have | 25, 157, 224 |
| abstract_inverted_index.mean | 136 |
| abstract_inverted_index.most | 145, 210 |
| abstract_inverted_index.rose | 175 |
| abstract_inverted_index.site | 212 |
| abstract_inverted_index.such | 55 |
| abstract_inverted_index.test | 90 |
| abstract_inverted_index.that | 144, 169, 226 |
| abstract_inverted_index.ways | 59 |
| abstract_inverted_index.well | 7 |
| abstract_inverted_index.were | 112 |
| abstract_inverted_index.will | 24 |
| abstract_inverted_index.with | 20, 208, 216 |
| abstract_inverted_index.(both | 235 |
| abstract_inverted_index.2021, | 207 |
| abstract_inverted_index.25.1% | 203 |
| abstract_inverted_index.Mali. | 57, 104 |
| abstract_inverted_index.Novel | 58 |
| abstract_inverted_index.[mean | 128 |
| abstract_inverted_index.after | 126 |
| abstract_inverted_index.allow | 71 |
| abstract_inverted_index.areas | 12, 242 |
| abstract_inverted_index.blood | 186 |
| abstract_inverted_index.cost. | 78 |
| abstract_inverted_index.crude | 183 |
| abstract_inverted_index.early | 151 |
| abstract_inverted_index.field | 101 |
| abstract_inverted_index.found | 168 |
| abstract_inverted_index.hours | 153 |
| abstract_inverted_index.human | 64, 92, 233 |
| abstract_inverted_index.large | 27 |
| abstract_inverted_index.least | 123 |
| abstract_inverted_index.scale | 43 |
| abstract_inverted_index.urban | 211 |
| abstract_inverted_index.using | 227 |
| abstract_inverted_index.where | 243 |
| abstract_inverted_index.would | 70 |
| abstract_inverted_index.young | 22 |
| abstract_inverted_index.46.7%, | 214 |
| abstract_inverted_index.across | 197 |
| abstract_inverted_index.cannot | 5 |
| abstract_inverted_index.during | 150, 176 |
| abstract_inverted_index.likely | 155 |
| abstract_inverted_index.method | 69 |
| abstract_inverted_index.night) | 161 |
| abstract_inverted_index.sites, | 199 |
| abstract_inverted_index.spread | 2 |
| abstract_inverted_index.venous | 218 |
| abstract_inverted_index.viable | 163 |
| abstract_inverted_index.October | 193 |
| abstract_inverted_index.Results | 105 |
| abstract_inverted_index.broadly | 61 |
| abstract_inverted_index.common, | 247 |
| abstract_inverted_index.disease | 17 |
| abstract_inverted_index.feeding | 127 |
| abstract_inverted_index.further | 34 |
| abstract_inverted_index.indoors | 149 |
| abstract_inverted_index.levels. | 181 |
| abstract_inverted_index.limited | 50 |
| abstract_inverted_index.medical | 46 |
| abstract_inverted_index.morning | 152 |
| abstract_inverted_index.numbers | 28 |
| abstract_inverted_index.option. | 255 |
| abstract_inverted_index.overall | 204 |
| abstract_inverted_index.readily | 113 |
| abstract_inverted_index.reduced | 77 |
| abstract_inverted_index.sampled | 187 |
| abstract_inverted_index.samples | 164 |
| abstract_inverted_index.setting | 54 |
| abstract_inverted_index.through | 121 |
| abstract_inverted_index.trained | 45 |
| abstract_inverted_index.without | 13 |
| abstract_inverted_index.Approach | 79 |
| abstract_inverted_index.February | 206 |
| abstract_inverted_index.November | 195 |
| abstract_inverted_index.antigens | 111, 174 |
| abstract_inverted_index.capacity | 14 |
| abstract_inverted_index.detected | 114 |
| abstract_inverted_index.diseases | 234 |
| abstract_inverted_index.evaluate | 82 |
| abstract_inverted_index.mosquito | 116, 228 |
| abstract_inverted_index.multiple | 109 |
| abstract_inverted_index.offering | 248 |
| abstract_inverted_index.pandemic | 178 |
| abstract_inverted_index.possible | 240 |
| abstract_inverted_index.previous | 160 |
| abstract_inverted_index.reaching | 213 |
| abstract_inverted_index.sampling | 62, 254 |
| abstract_inverted_index.0.78–1) | 134 |
| abstract_inverted_index.Countries | 19 |
| abstract_inverted_index.analysis. | 166 |
| abstract_inverted_index.blood-fed | 87, 146 |
| abstract_inverted_index.collected | 148 |
| abstract_inverted_index.detection | 36 |
| abstract_inverted_index.effective | 16 |
| abstract_inverted_index.hindering | 35 |
| abstract_inverted_index.increased | 201 |
| abstract_inverted_index.locations | 102 |
| abstract_inverted_index.monitored | 8 |
| abstract_inverted_index.naturally | 86 |
| abstract_inverted_index.Background | 0 |
| abstract_inverted_index.SARS-CoV-2 | 4, 110, 173 |
| abstract_inverted_index.antibodies | 94, 107 |
| abstract_inverted_index.bead-based | 119 |
| abstract_inverted_index.bloodmeals | 117 |
| abstract_inverted_index.collection | 84 |
| abstract_inverted_index.consistent | 215 |
| abstract_inverted_index.estimates. | 221 |
| abstract_inverted_index.indicating | 143 |
| abstract_inverted_index.infection. | 38 |
| abstract_inverted_index.laboratory | 97 |
| abstract_inverted_index.mosquitoes | 88, 147, 189, 245 |
| abstract_inverted_index.population | 23, 65 |
| abstract_inverted_index.reactivity | 170 |
| abstract_inverted_index.understood | 10 |
| abstract_inverted_index.0.88–1)], | 142 |
| abstract_inverted_index.Conclusions | 222 |
| abstract_inverted_index.blood-based | 219 |
| abstract_inverted_index.bloodmeals, | 229 |
| abstract_inverted_index.immunoassay | 120 |
| abstract_inverted_index.independent | 217 |
| abstract_inverted_index.infections, | 33 |
| abstract_inverted_index.large-scale | 73 |
| abstract_inverted_index.sensitivity | 129 |
| abstract_inverted_index.specificity | 137 |
| abstract_inverted_index.asymptomatic | 30 |
| abstract_inverted_index.country-wide | 42, 230 |
| abstract_inverted_index.demonstrated | 225 |
| abstract_inverted_index.human-biting | 244 |
| abstract_inverted_index.informative, | 250 |
| abstract_inverted_index.non-invasive | 68, 253 |
| abstract_inverted_index.pre-pandemic | 180 |
| abstract_inverted_index.surveillance | 74 |
| abstract_inverted_index.vector-borne | 236 |
| abstract_inverted_index.professionals | 47 |
| abstract_inverted_index.surveillance. | 18 |
| abstract_inverted_index.seropositivity | 184 |
| abstract_inverted_index.anti-SARS-CoV-2 | 93 |
| abstract_inverted_index.cost-effective, | 251 |
| abstract_inverted_index.Immunoglobulin-G | 106 |
| abstract_inverted_index.resource-limited | 53 |
| abstract_inverted_index.Sero-surveillance | 39 |
| abstract_inverted_index.non-vector-borne) | 238 |
| abstract_inverted_index.pauci-symptomatic | 32 |
| abstract_inverted_index.sero-surveillance | 220, 231 |
| abstract_inverted_index.disproportionately | 26 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5055609794 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 16 |
| corresponding_institution_ids | https://openalex.org/I4210159747 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.75 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.32952984 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |